Investigating factors influencing childhood obesity
Official title: Early Brain Development and Child Nutrition and Obesity
Run by Johns Hopkins University · NCT06861868 · Data updated 2026-11-12
This study looks at why some kids become overweight by checking their eating habits, genetics, and brain development to find ways to help prevent or treat obesity early on.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 7 Years to 12 Years |
| Sex | All |
| Enrollment | 210 (estimated) |
| Sponsor | Johns Hopkins University Academic / other |
| Locations | 4 sites (Baltimore, Maryland and 3 other locations) |
| Status | Recruiting |
| Started | December 2, 2024 |
| Main results expected | March 31, 2029 |
| Study ends | March 31, 2029 |
| Registry record updated | May 7, 2026 |
| Trial ID | NCT06861868 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 7-12 years from the RESONANCE cohort with no food allergies.
✕Probably not a fit
Patients with a history of neurological, psychiatric, or developmental disorders, or those with contraindications for MRI, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The RESONATE project aims to understand why some children develop obesity by analyzing data on eating behaviors, genetic and environmental influences, and brain structure and function. This observational study focuses on a sub-sample of families from the larger RESONANCE study, tracking children from infancy through middle childhood. By examining the neurodevelopmental mechanisms that affect appetite and weight gain, the study seeks to identify risk and protective factors that contribute to obesity. The findings will help lay the groundwork for early interventions to prevent or treat obesity in children.
Why it matters
Potential benefit: If successful, this study could lead to early interventions that effectively prevent or treat obesity in children.
How similar studies have gone: Other studies have shown success in understanding obesity through similar approaches, but this specific investigation into neurodevelopmental mechanisms is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants from the RESONANCE cohort are eligible if the participant will reach 7-12 years of age during the proposed project period and have no food allergies. Exclusion Criteria: * Exclusion criteria for RESONANCE include: 1. In utero exposure to alcohol, cigarette, or illicit substances; 2. First trimester fetal US abnormalities; 3. Complicated pregnancy (e.g., pre-eclampsia); 4. Complicated delivery, including APGAR scores less than 8 and/or neonatal intensive care unit (NICU) admission; 5. History of neurological (e.g., epilepsy), psychiatric (e.g., anxiety or depression requiring treatment with medication) or developmental disorder (e.g., autism spectrum disorder (ASD), dyslexia); 6. Contraindications for MRI including metal in the body, claustrophobia.
Where it's running
-
Rhode Island Hospital
Providence, Rhode Island, United States Recruiting -
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Baltimore, Maryland, United States Active not recruiting -
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States Active not recruiting -
University of Washington
Seattle, Washington, United States Active not recruiting
Study contacts
- Principal investigator: Susan Carnell, PhD — Johns Hopkins University
- Study coordinator: Susan Carnell, PhD
- Email: susan.carnell@jhmi.edu
- Phone: 410-955-7192
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
IBI3046 in Overweight or Obesity
This study tests how safe and tolerable IBI3046 is in adults with overweight or obesity in China.
-
Sleep behavioral program for adolescents with overweight or obesity
This trial will test whether adding a sleep-focused behavioral program to usual weight treatment helps teens (13–17) with overweight or obesity who have poor sleep improve body composition and health markers.
-
Robotic versus laparoscopic conversion to RYGB for revision bariatric surgery
We will see if robotic surgery or laparoscopy leads to fewer postoperative complications for people having revision bariatric surgery converted to RYGB.
-
Bone health, vitamin D, weight, and fractures in children
See if blood markers (alkaline phosphatase, calcium, PTH, vitamin D), body weight, and calcium intake are linked to fractures in children aged 3–15 after low-energy trauma.
-
Efsubaglutide alfa for adults with overweight or obesity (SPARKLE)
This trial will test whether efsubaglutide alfa injections given weekly or every few weeks help adults with overweight or obesity lose weight safely.
-
Cardiovascular health in children and young adults with chronic conditions
This project will see if children and young adults (ages 6-25) with chronic health conditions show early signs of aging in large and small blood vessels using noninvasive imaging and clinical tests.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.